Joshua Hare

Joshua Hare

Fondateur chez LONGEVERON INC.

Fortune : 225 018 $ au 31/08/2025

64 ans
Health Technology
Consumer Services
Commercial Services

Profil

Joshua M.
Hare
is the founder of Biscayne Pharmaceuticals, Inc., founded in 2012.
Dr. Hare is the founder of Longeveron, Inc., founded in 2014, and holds the title of Executive Chairman & Chief Science Officer since 2025.
Dr. Hare is also the founder of Vestion, Inc.,Heart Genomics LLC..
Dr. Hare currently serves as Director of the Interdisciplinary Stem Cell Institute at The University of Miami Leonard M.
Miller School of Medicine.
Dr. Hare is a member of the Association of American Physicians and the American Society for Clinical Investigation.
Dr. Hare completed undergraduate education at the University of Pennsylvania and earned a doctorate from The Johns Hopkins University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
30/04/2026 291 465 ( 0,97 % ) 225 011 $ 31/05/2026
30/04/2026 726 291 ( 48,94 % ) 7 $ 31/08/2025

Postes actifs de Joshua Hare

SociétésPosteDébut
LONGEVERON INC. Fondateur 09/10/2014
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Anciens postes connus de Joshua Hare

SociétésPosteFin
Fondateur -
Fondateur -
Fondateur -
Voir l'expérience en détail de Joshua Hare

Formation de Joshua Hare

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

42

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Consumer Services

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Services

Commercial Services

  1. Bourse
  2. Insiders
  3. Joshua Hare
🔇